Alan B. Bergman insider trades
Open-market stock purchases and sales by Alan B. Bergman, Chief Financial Officer at 20/20 Biolabs, Inc, from SEC Form 4 filings since Mar 10, 2022.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Apr 2, 2026 | AIDX 20/20 Biolabs, Inc | Bought (not open market) | — |